Navigation Links
William F. Prendergast Named One of the Top IP Lawyers in Nanotechnology
Date:8/8/2008

CHICAGO, Aug. 8 /PRNewswire/ -- Brinks Hofer Gilson & Lione, one of the largest intellectual property law firms in the United States, is pleased to announce that William F. Prendergast, a shareholder and chair of the firm's Nanotechnology Group, one of the largest nanotechnology practices in the nation, has been named one of the top 10 intellectual property lawyers influencing the field of Nanotechnology according to Nanotechnology Law & Business.

The publication cites Mr. Prendergast's accomplishments in the growth of the nanotechnology industry as internationally recognized, noting his participation as a member of the NanoBusiness Alliance, the leading trade organization in the United States, and as a sponsor of nanotechnology lectures at Brinks that have features highly respected authorities in the field. Also, Mr. Prendergast has lectured, written and taught around the world on the nanotechnology IP issues.

Mr. Prendergast's law practice focuses on a broad range of IP matters, including patent opinions, patent prosecution, licensing agreements to reviews of nanotechnology patent portfolios. His clients include Fortune 500 companies and major universities as well as start-up companies. He has worked with technologies including quantum dots, carbon nanotubes and advanced materials.

Nanotechnology Law & Business is a peer reviewed journal devoted to the legal, business and policy aspects of nanotechnology. The lawyers selected for its Top Ten list were selected on factors such as the number of patents prosecuted, types of clients and the degree of one's involvement in the nanotech community.

Founded in 1917, Brinks Hofer Gilson & Lione is based in Chicago with five additional offices across the country serving the intellectual property needs of clients from around the world. The firm is one of the largest IP law firms in the country, with more than 170 attorneys, scientific advisors and patent agents specializing in intellectual property litigation and all aspects of patent, trademark, copyright, trade secret, unfair competition, intellectual asset management, and technology and licensing agreements. Brinks routinely handles assignments in fields as diverse as electrical, chemical, mechanical, biotechnology, pharmaceutical, nanotechnology, Internet and computer technology, as well as in trademarks and brand names for a wide variety of products and services. For more information, visit http://www.usebrinks.com.

CONTACT:

Sydney Iglitzen

(312) 840-3163

siglitzen@usebrinks.com


'/>"/>
SOURCE Brinks Hofer Gilson & Lione
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Cepheid to Present at William Blair Small-Cap Growth Stock Conference
2. Mediatech Moves to Prince William County Innovation Park
3. Accera, Inc. Names William T. Poncy Vice President of Commercial Development
4. William Garland Joins AngioGenexs New Board of Directors
5. Amarin Appoints Dr. William Mason as Lead Independent Director
6. Vion Pharmaceuticals Adds William Hahne, M.D. to Senior Management Team
7. Biotech Pioneer William J. Rutter to Deliver Keynote at 2008 RAPS Horizons Conference
8. Investor Alert from Cauley Bowman Carney & Williams, PLLC: Update on Proposed Acquisition of CollaGenex Pharmaceuticals, Inc. - CGPI
9. Kendle Appoints Patricia Williams Vice President, Commercial Operations
10. NxStage Medical to Present at William Blair Growth Stock Conference
11. NuVasive to Present at William Blair 28th Annual Growth Stock Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... 18, 2017 The global biotechnology services ... billion by 2025, according to a new report ... been adaptive of the function of outsourcing certain ... Among the services outsourced, clinical trial management and ... & Johnson was the first pharmaceutical company to ...
(Date:1/19/2017)... 2017 BD (Becton, Dickinson and Company) (NYSE: ... will host a live webcast of its Annual Meeting of Shareholders ... The webcast can be accessed from the BD corporate website ... January 31, 2017. ... About BD BD is a global medical technology company ...
(Date:1/18/2017)... CAMBRIDGE, Mass. , Jan. 18, 2017   ... of novel compounds designed to target cancer stemness pathways, ... lead investigational compound, napabucasin, at the 2017 ASCO Gastrointestinal ... San Francisco . Napabucasin is ... pathways by targeting STAT3. i Cancer stem cells ...
(Date:1/18/2017)... ... 18, 2017 , ... Executive search firm Slone Partners proudly ... to the advancement of the clinical trials segment. Hosted in Miami, this conference ... planning and management. , As executive talent specialists in the industries central ...
Breaking Biology Technology:
(Date:12/16/2016)... Research and Markets has announced the addition of the ... report to their offering. ... The biometric vehicle access system market, in terms ... from 2016 to 2021. The market is estimated to be USD ... by 2021. The growth of the biometric vehicle access system market ...
(Date:12/15/2016)... Advancements in biometrics will radically ... wellbeing (HWW), and security of vehicles by ... vehicles begin to feature fingerprint recognition, iris ... monitoring, brain wave monitoring, stress detection, fatigue ... detection. These will be driven by built-in, ...
(Date:12/8/2016)... ALAMEDA, Calif. , Dec. 8, 2016  Singulex, ... Single Molecule Counting technology, entered into a license and ... in serving science. The agreement provides Singulex access to ... Europe is used to diagnose ... the United States to aid in assessing ...
Breaking Biology News(10 mins):